DGI-059 Safety of Anti-Epidermal Growth Factor Receptor Agents: Cetuximab and Panitumumab: Abstract DGI-059 Table 1
نویسندگان
چکیده
منابع مشابه
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
Acquired resistance to epidermal growth factor receptor (EGFR) targeted antibodies represents a clinical challenge in the treatment of gastrointestinal tumors such as metastatic colorectal cancer, but its molecular mechanisms are incompletely understood. We scanned KRAS exon 2/3/4, NRAS exon 2/3/4 and the overlapping epitopes of the EGFR antibodies cetuximab and panitumumab for mutations in pre...
متن کاملMpi Tr-059
Pigeons are known to be able to categorize a wide variety of visual stimulus classes. However, it remains unclear which are the characteristics of the perceptually relevant features employed to reach such good performance. Here, we investigate the relative contributions of texture and shape information to categorization decisions about complex natural classes. We trained three groups of pigeons...
متن کامل059-067 Gram
Introduction Listeriosis is a food-borne disease which primarily affects people in particular risk-groups (immuno-suppressed, elderly, neonates) in which lethality is as high as 25%. The disease does occur in out-breaks but most cases appear as sporadic cases. The disease is primarily associated with ready-to-eat (RTE) food products with extended (refrigerated) shelf life. Outbreaks have mostly...
متن کاملAltered Expression of Epidermal Growth Factor Receptor (EGFR) in Glioma
EGFR is a key molecule in cancer cells. EGFR signaling was shown to promote tumor cell proliferation and survival, invasion and angiogenesis and mediate resistance to treatment, including ionizing radiation in preclinical models. We extracted proteins from astrocytoma (III and IV) oligodendroglioma(IV) tumors and normal brain tissues and then evaluated the protein purity by Bradford test ...
متن کاملTargeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
The tumor biology targeted therapies have improved outcomes in colorectal cancer (CRC). The epidermal growth factor receptor (EGFR) inhibitors represent one of these successful strategies. EGFR is frequently overexpressed in CRCs and associated with a malignant phenotype. Two EGFR inhibitors have shown efficacy in metastatic CRC, cetuximab and panitumumab. Cetuximab is a human-mouse chimeric mo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Hospital Pharmacy
سال: 2013
ISSN: 2047-9956,2047-9964
DOI: 10.1136/ejhpharm-2013-000276.325